Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07874009 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Can Adjunctive Oral Magnesium Supplementation Prolong the Effect of Botulinum Toxin Type A in Excessive Gingival Display?

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Cairo University
1,562 trials monitored
See 18 trials at risk
To evaluate and compare the effect of adjuvant oral magnesium supplementation combined with Botulinum Toxin Type A versus Botulinum Toxin Type A alone on the reduction of millimeter gingival display and the duration of clinical effectiveness in patients with excessive gingival display
Trial Details
NCT Number NCT07874009
Lead Sponsor Cairo University
Conditions
(from sponsor)		 Magnesium, Botulinum Toxin Type A, Excessive Gingival Display, Oral
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov